logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9855315 B1

PDFFull Text
Date of Patent:
Jan. 02, 2018

Filed:

Mar. 10, 2011

Pharmaceutical composition comprising ccn5 for reducing cardiac fibrosis in a subject in need thereof

Applicants:

Woo Jin Park, Seoul, KR;

Pyoung OH Yoon, Gwangju, KR;

Dong Kwon Yang, Gwangju, KR;

Inventors:

Woo Jin Park, Seoul, KR;

Pyoung Oh Yoon, Gwangju, KR;

Dong Kwon Yang, Gwangju, KR;

Assignee:

BETHPHAGEN INC., Buk-Gu, Gwangju, KR;

Attorney:

Harness, Dickey & Pierce, P.L.C.

Primary Examiner:

Titilayo Moloye

Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61K 38/18 (2006.01); C07K 14/475 (2006.01); G01N 33/68 (2006.01); A61K 31/7088 (2006.01); A61K 38/17 (2006.01); A01K 67/027 (2006.01);
U.S. Cl.
CPC ...
A61K 38/18 (2013.01); A61K 31/7088 (2013.01); A61K 38/179 (2013.01); C07K 14/475 (2013.01); G01N 33/6893 (2013.01); A01K 67/0275 (2013.01); C12N 2799/022 (2013.01); G01N 2800/325 (2013.01);
Abstract

The present invention relates to a pharmaceutical composition for preventing or treating a heart failure and a method for screening a therapeutic agent for preventing or treating a heart failure. The pharmaceutical composition of the present disclosure comprises the CCN5 or CCN2ΔCT protein, or a genetic carrier comprising a nucleotide sequence encoding the CCN5 or the CCN2ΔCT protein, exhibiting dramatic prevention or treatment efficacies on a heart failure even without surgical treatments accompanied with transplanting a donor heart.

Find Patent Forward Citations

Park, Woo. (2018). Pharmaceutical composition comprising ccn5 for reducing cardiac fibrosis in a subject in need thereof (U.S. Patent No. 9855315). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9855315

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…